Mark S. Lesney, PhD
Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections
January 29, 2021
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”
Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?
November 10, 2020
Environmental pollution during the COVID-19 pandemic puts dolphins, whales, seals, and otters among the sea mammals at risk.
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
October 20, 2020
Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival, comparable with the general population.
Blood group O linked to decreased risk of SARS-CoV-2 infection
October 15, 2020
A retrospective analysis of all Danish individuals with a known ABO blood group tested for SARS-CoV-2 showed a lower infection risk for SARS-CoV-2 infection in blood group O.